CVRx to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call on Nov. 5, 2025
CVRx (NASDAQ: CVRX) will release third quarter 2025 financial and operating results after market close on Wednesday, Nov. 5, 2025. The company will host a conference call to review results on Nov. 5, 2025 at 4:30 p.m. Eastern Time.
A live webcast will be available at the company investor relations page (ir.cvrx.com). U.S. telephone dial-in is 1-877-704-4453; international dial-in is 1-201-389-0920. Callers are asked to dial in approximately ten minutes before the start time.
CVRx (NASDAQ: CVRX) pubblicherà i risultati finanziari e operativi del terzo trimestre 2025 dopo la chiusura del mercato di mercoledì 5 novembre 2025. L'azienda terrà una conference call per rivedere i risultati il 5 novembre 2025 alle 16:30 ora orientale. Una webcast in diretta sarà disponibile sulla pagina relazioni con gli investitori dell'azienda (ir.cvrx.com). Il numero di accesso telefonico USA è 1-877-704-4453; l'accesso internazionale è 1-201-389-0920. Si invita i chiamanti a chiamare circa dieci minuti prima dell'orario di inizio.
CVRx (NASDAQ: CVRX) publicará los resultados financieros y operativos del tercer trimestre de 2025 después del cierre del mercado el miércoles 5 de noviembre de 2025. La compañía organizará una conferencia telefónica para revisar los resultados el 5 de noviembre de 2025 a las 4:30 p.m. hora del Este. Un webcast en vivo estará disponible en la página de relaciones con inversores de la empresa (ir.cvrx.com). El marcado desde EE. UU. es 1-877-704-4453; el acceso internacional es 1-201-389-0920. Se solicita a los llamantes que marquen aproximadamente diez minutos antes de la hora de inicio.
CVRx (NASDAQ: CVRX)는 2025년 3분기 재무 및 운영 실적을 2025년 11월 5일 수요일 장 마감 후에 발표합니다. 회사는 실적 검토를 위한 컨퍼런스 콜을 2025년 11월 5일 동부시간 4:30 p.m.에 개최합니다. 실시간 웹캐스트는 회사 투자자 관계 페이지(ir.cvrx.com)에서 이용 가능합니다. 미국 전화 다이얼인 번호는 1-877-704-4453; 국제 다이얼인은 1-201-389-0920입니다. 시작 시각 약 10분 전에 전화해 주시기 바랍니다.
CVRx (NASDAQ: CVRX) publiera les résultats financiers et opérationnels du troisième trimestre 2025 après la clôture du marché le mercredi 5 novembre 2025. La société organisera une conférence téléphonique pour examiner les résultats le 5 novembre 2025 à 16 h 30, heure de l'Est. Une diffusion en direct sera disponible sur la page relations investisseurs de la société (ir.cvrx.com). Le numéro d'appel américain est 1-877-704-4453; l'accès international est 1-201-389-0920. Les appelants sont priés d'appeler environ dix minutes avant l'heure de début.
CVRx (NASDAQ: CVRX) wird die Ergebnisse des dritten Quartals 2025 finanziell und operativ nach Börsenschluss am Mittwoch, dem 5. November 2025 veröffentlichen. Das Unternehmen wird eine Telefonkonferenz zur Besprechung der Ergebnisse am 5. November 2025 um 16:30 Uhr Eastern Time abhalten. Ein Live-Webcast ist verfügbar auf der Investor Relations-Seite des Unternehmens (ir.cvrx.com). Die US-Telefon-Teilnahme lautet 1-877-704-4453; internationale Teilnahme ist 1-201-389-0920. Teilnehmer werden gebeten, sich etwa zehn Minuten vor Beginn einzuwählen.
CVRx (شركة مدرجة في ناسداك: CVRX) ستصدر نتائجها المالية والتشغيلية للربع الثالث من عام 2025 بعد إغلاق السوق يوم الأربعاء 5 نوفمبر 2025. ستعقد الشركة مكالمة جماعية لاستعراض النتائج في 5 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت شرق الولايات المتحدة. سيكون هناك بث حي على صفحة العلاقات مع المستثمرين للشركة (ir.cvrx.com). الرقم الأميركي للاتصال هو 1-877-704-4453؛ الوصول الدولي هو 1-201-389-0920. يُطلب من المتصلين الاتصال قبل حوالي عشر دقائق من وقت البدء.
CVRx (NASDAQ: CVRX) 将于 2025年11月5日（星期三）美国东部时间4:30 p.m. 在市场收盘后发布 2025 年第三季度的财务和运营业绩。公司将于 2025年11月5日 美国东部时间下午4:30 举行电话会议以回顾业绩。现场 webcast 将在公司投资者关系页面提供(ir.cvrx.com)。美国电话拨入为 1-877-704-4453；国际拨入为 1-201-389-0920。请来宾在开始时间前大约十分钟拨入。
- None.
- None.
MINNEAPOLIS, Oct. 22, 2025 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, today announced that it plans to release third quarter 2025 financial and operating results after market close on Wednesday, Nov. 5, 2025. The Company will host a conference call to review its results at 4:30 p.m. Eastern Time the same day.
A live webcast of the investor conference call will be available online at the investor relations page of the Company’s website at ir.cvrx.com. To listen to the conference call on your telephone, please dial 1- 877-704-4453 for U.S. callers, or 1-201-389-0920 for international callers, approximately ten minutes prior to the start time.
About CVRx, Inc.
CVRx is a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases. Barostim™ is the first medical technology approved by FDA that uses neuromodulation to improve the symptoms of patients with heart failure. Barostim is an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery. The therapy is designed to restore balance to the autonomic nervous system and thereby reduce the symptoms of heart failure. Barostim received the FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. It has been certified as compliant with the EU Medical Device Regulation (MDR) and holds CE Mark for heart failure and resistant hypertension in the European Economic Area. To learn more about Barostim, visit www.cvrx.com.
Investor Contact:
Mark Klausner or Mike Vallie
ICR Healthcare
443-213-0501
ir@cvrx.com
Media Contact:
Emily Meyers
CVRx, Inc.
763-416-2853
emeyers@cvrx.com
FAQ
When will CVRx (CVRX) report third quarter 2025 results?
What time is the CVRx (CVRX) conference call on Nov. 5, 2025?
How can I listen to the CVRx (CVRX) webcast of the Nov. 5, 2025 call?
What are the dial-in numbers for the CVRx (CVRX) Nov. 5, 2025 call?
Will CVRx (CVRX) provide financial details during the Nov. 5, 2025 call?
